Integrity Applications Signs Third Distribution Agreement For Glucotrack® Model DF-F Glucose Monitoring Device

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ASHKELON, Israel--(BUSINESS WIRE)--Integrity Applications, Inc. (OTCQB: IGAP), developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, has entered, through its subsidiary company, Integrity Applications Ltd., into a distribution agreement appointing Felkasta JSC as the exclusive distributor of the GlucoTrack device in Lithuania, Latvia, Estonia and Belarus effective March 28, 2014. According to the International Diabetes Federation, a total of 281,000 people with diabetes live in Lithuania, Latvia and Estonia combined, while 445,000 people with diabetes live in Belarus.

Help employers find you! Check out all the jobs and post your resume.

Back to news